1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gefitinib Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gefitinib Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gefitinib Tablets by Country/Region, 2018, 2022 & 2029
2.2 Gefitinib Tablets Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Gefitinib Tablets Sales by Type
2.3.1 Global Gefitinib Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Gefitinib Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gefitinib Tablets Sale Price by Type (2018-2023)
2.4 Gefitinib Tablets Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Other
2.5 Gefitinib Tablets Sales by Application
2.5.1 Global Gefitinib Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Gefitinib Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gefitinib Tablets Sale Price by Application (2018-2023)
3 Global Gefitinib Tablets by Company
3.1 Global Gefitinib Tablets Breakdown Data by Company
3.1.1 Global Gefitinib Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Gefitinib Tablets Sales Market Share by Company (2018-2023)
3.2 Global Gefitinib Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Gefitinib Tablets Revenue by Company (2018-2023)
3.2.2 Global Gefitinib Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Gefitinib Tablets Sale Price by Company
3.4 Key Manufacturers Gefitinib Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gefitinib Tablets Product Location Distribution
3.4.2 Players Gefitinib Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gefitinib Tablets by Geographic Region
4.1 World Historic Gefitinib Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Gefitinib Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gefitinib Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gefitinib Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Gefitinib Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gefitinib Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gefitinib Tablets Sales Growth
4.4 APAC Gefitinib Tablets Sales Growth
4.5 Europe Gefitinib Tablets Sales Growth
4.6 Middle East & Africa Gefitinib Tablets Sales Growth
5 Americas
5.1 Americas Gefitinib Tablets Sales by Country
5.1.1 Americas Gefitinib Tablets Sales by Country (2018-2023)
5.1.2 Americas Gefitinib Tablets Revenue by Country (2018-2023)
5.2 Americas Gefitinib Tablets Sales by Type
5.3 Americas Gefitinib Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gefitinib Tablets Sales by Region
6.1.1 APAC Gefitinib Tablets Sales by Region (2018-2023)
6.1.2 APAC Gefitinib Tablets Revenue by Region (2018-2023)
6.2 APAC Gefitinib Tablets Sales by Type
6.3 APAC Gefitinib Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gefitinib Tablets by Country
7.1.1 Europe Gefitinib Tablets Sales by Country (2018-2023)
7.1.2 Europe Gefitinib Tablets Revenue by Country (2018-2023)
7.2 Europe Gefitinib Tablets Sales by Type
7.3 Europe Gefitinib Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gefitinib Tablets by Country
8.1.1 Middle East & Africa Gefitinib Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gefitinib Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Gefitinib Tablets Sales by Type
8.3 Middle East & Africa Gefitinib Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gefitinib Tablets
10.3 Manufacturing Process Analysis of Gefitinib Tablets
10.4 Industry Chain Structure of Gefitinib Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gefitinib Tablets Distributors
11.3 Gefitinib Tablets Customer
12 World Forecast Review for Gefitinib Tablets by Geographic Region
12.1 Global Gefitinib Tablets Market Size Forecast by Region
12.1.1 Global Gefitinib Tablets Forecast by Region (2024-2029)
12.1.2 Global Gefitinib Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gefitinib Tablets Forecast by Type
12.7 Global Gefitinib Tablets Forecast by Application
13 Key Players Analysis
13.1 Qilu Pharmaceutical
13.1.1 Qilu Pharmaceutical Company Information
13.1.2 Qilu Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.1.3 Qilu Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Qilu Pharmaceutical Main Business Overview
13.1.5 Qilu Pharmaceutical Latest Developments
13.2 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.2.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.2.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.2.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Portfolios and Specifications
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
13.4.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
13.4.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.4.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
13.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.6 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
13.6.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
13.6.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.6.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
13.7 Shanghai DESANO Pharmaceuticals Holding Co., Ltd.
13.7.1 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
13.7.2 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
13.7.3 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business Overview
13.7.5 Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
13.8 NatcoPharma
13.8.1 NatcoPharma Company Information
13.8.2 NatcoPharma Gefitinib Tablets Product Portfolios and Specifications
13.8.3 NatcoPharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 NatcoPharma Main Business Overview
13.8.5 NatcoPharma Latest Developments
13.9 AstraZeneca plc
13.9.1 AstraZeneca plc Company Information
13.9.2 AstraZeneca plc Gefitinib Tablets Product Portfolios and Specifications
13.9.3 AstraZeneca plc Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AstraZeneca plc Main Business Overview
13.9.5 AstraZeneca plc Latest Developments
13.10 Intelicure Lifesciences
13.10.1 Intelicure Lifesciences Company Information
13.10.2 Intelicure Lifesciences Gefitinib Tablets Product Portfolios and Specifications
13.10.3 Intelicure Lifesciences Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Intelicure Lifesciences Main Business Overview
13.10.5 Intelicure Lifesciences Latest Developments
13.11 Weefsel Pharma
13.11.1 Weefsel Pharma Company Information
13.11.2 Weefsel Pharma Gefitinib Tablets Product Portfolios and Specifications
13.11.3 Weefsel Pharma Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Weefsel Pharma Main Business Overview
13.11.5 Weefsel Pharma Latest Developments
13.12 Taj Pharmaceuticals
13.12.1 Taj Pharmaceuticals Company Information
13.12.2 Taj Pharmaceuticals Gefitinib Tablets Product Portfolios and Specifications
13.12.3 Taj Pharmaceuticals Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Taj Pharmaceuticals Main Business Overview
13.12.5 Taj Pharmaceuticals Latest Developments
13.13 Saintroy Lifescience
13.13.1 Saintroy Lifescience Company Information
13.13.2 Saintroy Lifescience Gefitinib Tablets Product Portfolios and Specifications
13.13.3 Saintroy Lifescience Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Saintroy Lifescience Main Business Overview
13.13.5 Saintroy Lifescience Latest Developments
13.14 Actiza Pharmaceutical
13.14.1 Actiza Pharmaceutical Company Information
13.14.2 Actiza Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
13.14.3 Actiza Pharmaceutical Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Actiza Pharmaceutical Main Business Overview
13.14.5 Actiza Pharmaceutical Latest Developments
13.15 Teva
13.15.1 Teva Company Information
13.15.2 Teva Gefitinib Tablets Product Portfolios and Specifications
13.15.3 Teva Gefitinib Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Teva Main Business Overview
13.15.5 Teva Latest Developments
14 Research Findings and Conclusion
Table 1. Gefitinib Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gefitinib Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global Gefitinib Tablets Sales by Type (2018-2023) & (K Units)
Table 6. Global Gefitinib Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Gefitinib Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Gefitinib Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Gefitinib Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Gefitinib Tablets Sales by Application (2018-2023) & (K Units)
Table 11. Global Gefitinib Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Gefitinib Tablets Revenue by Application (2018-2023)
Table 13. Global Gefitinib Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Gefitinib Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Gefitinib Tablets Sales by Company (2018-2023) & (K Units)
Table 16. Global Gefitinib Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Gefitinib Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Gefitinib Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Gefitinib Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Gefitinib Tablets Producing Area Distribution and Sales Area
Table 21. Players Gefitinib Tablets Products Offered
Table 22. Gefitinib Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gefitinib Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Gefitinib Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Gefitinib Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Gefitinib Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Gefitinib Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Gefitinib Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Gefitinib Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Gefitinib Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Gefitinib Tablets Sales by Country (2018-2023) & (K Units)
Table 34. Americas Gefitinib Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Gefitinib Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Gefitinib Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Gefitinib Tablets Sales by Type (2018-2023) & (K Units)
Table 38. Americas Gefitinib Tablets Sales by Application (2018-2023) & (K Units)
Table 39. APAC Gefitinib Tablets Sales by Region (2018-2023) & (K Units)
Table 40. APAC Gefitinib Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Gefitinib Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Gefitinib Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Gefitinib Tablets Sales by Type (2018-2023) & (K Units)
Table 44. APAC Gefitinib Tablets Sales by Application (2018-2023) & (K Units)
Table 45. Europe Gefitinib Tablets Sales by Country (2018-2023) & (K Units)
Table 46. Europe Gefitinib Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Gefitinib Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Gefitinib Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Gefitinib Tablets Sales by Type (2018-2023) & (K Units)
Table 50. Europe Gefitinib Tablets Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Gefitinib Tablets Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Gefitinib Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Gefitinib Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Gefitinib Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Gefitinib Tablets Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Gefitinib Tablets Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Gefitinib Tablets
Table 58. Key Market Challenges & Risks of Gefitinib Tablets
Table 59. Key Industry Trends of Gefitinib Tablets
Table 60. Gefitinib Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Gefitinib Tablets Distributors List
Table 63. Gefitinib Tablets Customer List
Table 64. Global Gefitinib Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Gefitinib Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Gefitinib Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Gefitinib Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Gefitinib Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Gefitinib Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Gefitinib Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Gefitinib Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Gefitinib Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Gefitinib Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Gefitinib Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Gefitinib Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Gefitinib Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Gefitinib Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Qilu Pharmaceutical Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Qilu Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
Table 80. Qilu Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Qilu Pharmaceutical Main Business
Table 82. Qilu Pharmaceutical Latest Developments
Table 83. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 85. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business
Table 87. Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
Table 88. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 90. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 92. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 93. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 95. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Main Business
Table 97. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Latest Developments
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 100. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 102. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 103. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 105. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Main Business
Table 107. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Latest Developments
Table 108. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product Portfolios and Specifications
Table 110. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Main Business
Table 112. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Latest Developments
Table 113. NatcoPharma Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. NatcoPharma Gefitinib Tablets Product Portfolios and Specifications
Table 115. NatcoPharma Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. NatcoPharma Main Business
Table 117. NatcoPharma Latest Developments
Table 118. AstraZeneca plc Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. AstraZeneca plc Gefitinib Tablets Product Portfolios and Specifications
Table 120. AstraZeneca plc Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. AstraZeneca plc Main Business
Table 122. AstraZeneca plc Latest Developments
Table 123. Intelicure Lifesciences Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 124. Intelicure Lifesciences Gefitinib Tablets Product Portfolios and Specifications
Table 125. Intelicure Lifesciences Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Intelicure Lifesciences Main Business
Table 127. Intelicure Lifesciences Latest Developments
Table 128. Weefsel Pharma Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 129. Weefsel Pharma Gefitinib Tablets Product Portfolios and Specifications
Table 130. Weefsel Pharma Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Weefsel Pharma Main Business
Table 132. Weefsel Pharma Latest Developments
Table 133. Taj Pharmaceuticals Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 134. Taj Pharmaceuticals Gefitinib Tablets Product Portfolios and Specifications
Table 135. Taj Pharmaceuticals Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Taj Pharmaceuticals Main Business
Table 137. Taj Pharmaceuticals Latest Developments
Table 138. Saintroy Lifescience Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 139. Saintroy Lifescience Gefitinib Tablets Product Portfolios and Specifications
Table 140. Saintroy Lifescience Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Saintroy Lifescience Main Business
Table 142. Saintroy Lifescience Latest Developments
Table 143. Actiza Pharmaceutical Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 144. Actiza Pharmaceutical Gefitinib Tablets Product Portfolios and Specifications
Table 145. Actiza Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Actiza Pharmaceutical Main Business
Table 147. Actiza Pharmaceutical Latest Developments
Table 148. Teva Basic Information, Gefitinib Tablets Manufacturing Base, Sales Area and Its Competitors
Table 149. Teva Gefitinib Tablets Product Portfolios and Specifications
Table 150. Teva Gefitinib Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Teva Main Business
Table 152. Teva Latest Developments
List of Figures
Figure 1. Picture of Gefitinib Tablets
Figure 2. Gefitinib Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gefitinib Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gefitinib Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gefitinib Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drugs
Figure 10. Product Picture of Generic Drugs
Figure 11. Global Gefitinib Tablets Sales Market Share by Type in 2022
Figure 12. Global Gefitinib Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Gefitinib Tablets Consumed in Breast Cancer
Figure 14. Global Gefitinib Tablets Market: Breast Cancer (2018-2023) & (K Units)
Figure 15. Gefitinib Tablets Consumed in Lung Cancer
Figure 16. Global Gefitinib Tablets Market: Lung Cancer (2018-2023) & (K Units)
Figure 17. Gefitinib Tablets Consumed in Other
Figure 18. Global Gefitinib Tablets Market: Other (2018-2023) & (K Units)
Figure 19. Global Gefitinib Tablets Sales Market Share by Application (2022)
Figure 20. Global Gefitinib Tablets Revenue Market Share by Application in 2022
Figure 21. Gefitinib Tablets Sales Market by Company in 2022 (K Units)
Figure 22. Global Gefitinib Tablets Sales Market Share by Company in 2022
Figure 23. Gefitinib Tablets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Gefitinib Tablets Revenue Market Share by Company in 2022
Figure 25. Global Gefitinib Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Gefitinib Tablets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Gefitinib Tablets Sales 2018-2023 (K Units)
Figure 28. Americas Gefitinib Tablets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Gefitinib Tablets Sales 2018-2023 (K Units)
Figure 30. APAC Gefitinib Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Gefitinib Tablets Sales 2018-2023 (K Units)
Figure 32. Europe Gefitinib Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Gefitinib Tablets Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Gefitinib Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Gefitinib Tablets Sales Market Share by Country in 2022
Figure 36. Americas Gefitinib Tablets Revenue Market Share by Country in 2022
Figure 37. Americas Gefitinib Tablets Sales Market Share by Type (2018-2023)
Figure 38. Americas Gefitinib Tablets Sales Market Share by Application (2018-2023)
Figure 39. United States Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Gefitinib Tablets Sales Market Share by Region in 2022
Figure 44. APAC Gefitinib Tablets Revenue Market Share by Regions in 2022
Figure 45. APAC Gefitinib Tablets Sales Market Share by Type (2018-2023)
Figure 46. APAC Gefitinib Tablets Sales Market Share by Application (2018-2023)
Figure 47. China Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Gefitinib Tablets Sales Market Share by Country in 2022
Figure 55. Europe Gefitinib Tablets Revenue Market Share by Country in 2022
Figure 56. Europe Gefitinib Tablets Sales Market Share by Type (2018-2023)
Figure 57. Europe Gefitinib Tablets Sales Market Share by Application (2018-2023)
Figure 58. Germany Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Gefitinib Tablets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Gefitinib Tablets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Gefitinib Tablets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Gefitinib Tablets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Gefitinib Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Gefitinib Tablets in 2022
Figure 73. Manufacturing Process Analysis of Gefitinib Tablets
Figure 74. Industry Chain Structure of Gefitinib Tablets
Figure 75. Channels of Distribution
Figure 76. Global Gefitinib Tablets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Gefitinib Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Gefitinib Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Gefitinib Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Gefitinib Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Gefitinib Tablets Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
